STOK logo

Stoke Therapeutics, Inc. (STOK) Net Income

Annual Net Income:

-$88.98M+$15.72M(+15.01%)
December 31, 2024

Summary

  • As of today, STOK annual net profit is -$88.98 million, with the most recent change of +$15.72 million (+15.01%) on December 31, 2024.
  • During the last 3 years, STOK annual net income has fallen by -$3.18 million (-3.70%).
  • STOK annual net income is now -1500.95% below its all-time high of -$5.56 million, reached on December 31, 2017.

Performance

STOK Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

Quarterly Net Income:

-$38.35M-$14.86M(-63.30%)
September 30, 2025

Summary

  • As of today, STOK quarterly net profit is -$38.35 million, with the most recent change of -$14.86 million (-63.30%) on September 30, 2025.
  • Over the past year, STOK quarterly net income has dropped by -$11.92 million (-45.09%).
  • STOK quarterly net income is now -133.97% below its all-time high of $112.88 million, reached on March 31, 2025.

Performance

STOK Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

TTM Net Income:

$40.57M-$11.92M(-22.71%)
September 30, 2025

Summary

  • As of today, STOK TTM net profit is $40.57 million, with the most recent change of -$11.92 million (-22.71%) on September 30, 2025.
  • Over the past year, STOK TTM net income has increased by +$146.02 million (+138.47%).
  • STOK TTM net income is now -22.71% below its all-time high of $52.48 million, reached on June 30, 2025.

Performance

STOK TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSTOKincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

STOK Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+15.0%-45.1%+138.5%
3Y3 Years-3.7%-46.9%+140.6%
5Y5 Years-175.3%-180.2%+184.8%

STOK Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-3.7%+15.0%-134.0%at low-22.7%+137.4%
5Y5-Year-175.3%+15.0%-134.0%at low-22.7%+137.4%
All-TimeAll-Time-1501.0%+15.0%-134.0%at low-22.7%+137.4%

STOK Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
-$38.35M(-63.3%)
$40.57M(-22.7%)
Jun 2025
-
-$23.48M(-120.8%)
$52.48M(+4.4%)
Mar 2025
-
$112.88M(+1176.8%)
$50.27M(+156.5%)
Dec 2024
-$88.98M(+15.0%)
-$10.48M(+60.3%)
-$88.98M(+15.6%)
Sep 2024
-
-$26.43M(-2.9%)
-$105.46M(-1.8%)
Jun 2024
-
-$25.70M(+2.6%)
-$103.57M(+4.6%)
Mar 2024
-
-$26.37M(+2.2%)
-$108.53M(-3.7%)
Dec 2023
-$104.70M(-3.6%)
-$26.96M(-9.8%)
-$104.70M(-1.3%)
Sep 2023
-
-$24.54M(+19.9%)
-$103.40M(+1.5%)
Jun 2023
-
-$30.65M(-36.0%)
-$104.97M(-6.1%)
Mar 2023
-
-$22.55M(+12.1%)
-$98.96M(+2.1%)
Dec 2022
-$101.07M(-17.8%)
-$25.66M(+1.7%)
-$101.07M(-1.2%)
Sep 2022
-
-$26.11M(-5.9%)
-$99.86M(-3.6%)
Jun 2022
-
-$24.65M(-0.0%)
-$96.35M(-2.9%)
Mar 2022
-
-$24.65M(-0.8%)
-$93.66M(-9.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$85.81M(-64.2%)
-$24.45M(-8.2%)
-$85.81M(-13.0%)
Sep 2021
-
-$22.60M(-2.9%)
-$75.92M(-13.3%)
Jun 2021
-
-$21.97M(-30.8%)
-$67.00M(-15.5%)
Mar 2021
-
-$16.79M(-15.3%)
-$58.00M(-11.0%)
Dec 2020
-$52.24M(-61.6%)
-$14.56M(-6.4%)
-$52.24M(-9.2%)
Sep 2020
-
-$13.68M(-5.6%)
-$47.84M(-11.9%)
Jun 2020
-
-$12.96M(-17.4%)
-$42.76M(-13.7%)
Mar 2020
-
-$11.04M(-8.7%)
-$37.62M(-16.4%)
Dec 2019
-$32.33M(-158.2%)
-$10.16M(-18.1%)
-$32.33M(-45.8%)
Sep 2019
-
-$8.60M(-10.0%)
-$22.16M(-63.4%)
Jun 2019
-
-$7.82M(-36.2%)
-$13.56M(-136.2%)
Mar 2019
-
-$5.74M(-200.3%)
-$5.74M(-200.3%)
Dec 2018
-$12.52M(-125.3%)
-
-
Mar 2018
-
-$1.91M
-$1.91M
Dec 2017
-$5.56M
-
-

FAQ

  • What is Stoke Therapeutics, Inc. annual net profit?
  • What is the all-time high annual net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. annual net income year-on-year change?
  • What is Stoke Therapeutics, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Stoke Therapeutics, Inc. TTM net profit?
  • What is the all-time high TTM net income for Stoke Therapeutics, Inc.?
  • What is Stoke Therapeutics, Inc. TTM net income year-on-year change?

What is Stoke Therapeutics, Inc. annual net profit?

The current annual net income of STOK is -$88.98M

What is the all-time high annual net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high annual net profit is -$5.56M

What is Stoke Therapeutics, Inc. annual net income year-on-year change?

Over the past year, STOK annual net profit has changed by +$15.72M (+15.01%)

What is Stoke Therapeutics, Inc. quarterly net profit?

The current quarterly net income of STOK is -$38.35M

What is the all-time high quarterly net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high quarterly net profit is $112.88M

What is Stoke Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, STOK quarterly net profit has changed by -$11.92M (-45.09%)

What is Stoke Therapeutics, Inc. TTM net profit?

The current TTM net income of STOK is $40.57M

What is the all-time high TTM net income for Stoke Therapeutics, Inc.?

Stoke Therapeutics, Inc. all-time high TTM net profit is $52.48M

What is Stoke Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, STOK TTM net profit has changed by +$146.02M (+138.47%)
On this page